论文部分内容阅读
目的 :探讨中药肝胃舒合剂对肝癌患者肝动脉化疗栓塞术 (TACE )后消化道反应、免疫功能及肝功能损害的影响。方法 :5 4例原发性肝癌患者随机分为观察组和对照组 (每组 2 7例 )。对照组行 TACE及对症处理 ,观察组于 TACE前 3d口服肝胃舒合剂 ,其他治疗同对照组 ,进行疗效对比。结果 :观察组 TACE后消化道反应程度、肝功能损害明显较对照组轻 ,免疫功能的作用显著增强。结论 :肝胃舒合剂可减轻肝癌患者 TACE后的消化道反应及肝功能损害 ,增强免疫功能。
Objective: To investigate the effect of traditional Chinese medicine Ganweishu Mixture on gastrointestinal reactions, immune function and liver damage after hepatic artery chemoembolization (TACE) in patients with liver cancer. Methods: Fifty-four patients with primary liver cancer were randomly divided into observation group and control group (27 cases in each group). The control group underwent TACE and symptomatic treatment. The observation group was treated with Ganweishu Mixture three days before TACE, and the other treatments were compared with the control group. Results: The degree of digestive tract reaction after TACE in observation group was significantly lower than that in control group, and the immune function was significantly enhanced. Conclusion: Weishehuai can relieve the digestive tract reaction and hepatic dysfunction after TACE in patients with liver cancer and enhance the immune function.